News & Resources

A COVID-19 surge is underway that is starting to cause disruptions as the school year wraps up and Americans prepare for summer vacations.

Three doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5, the company announced Monday, another step toward shots for the littlest kids possibly beginning in early summer.

Friday May 20, 2022 12:00-12:30 ET Join experts from the Johns Hopkins Coronavirus Resource Center (CRC) at 12pm ET on Fridays for timely, accessible updates on the state of the pandemic and the public health response.

The U.S. has officially surpassed 1 million deaths from COVID-19, according to data Tuesday from John Hopkins University.

Since the Omicron wave crested in January, multiple studies and datasets have demonstrated that the mRNA vaccines are not nearly as effective against this variant as they were against earlier variants or the original virus.

Friday April 22, 2022 12:00-12:30 ET Join experts from the Johns Hopkins Coronavirus Resource Center (CRC) at 12pm ET on Fridays for timely, accessible updates on the state of the pandemic and the public health response.

According to the CDC, Pfizer-BioNTech or Moderna COVID-19 vaccine boosters are preferred for individuals who received the single-dose Johnson & Johnson shot.

The coronavirus is continuing to stalk the world at an astonishing clip, racing past a grim succession of pandemic milestones in 2022.

Adults 50 and older can now roll up their sleeves for a second COVID-19 booster, as can younger individuals with certain immune-compromising conditions.

More than 16 million Americans rolled up their sleeves last year to get Johnson & Johnson's COVID-19 vaccine because it promised to be a "one and done" shot, but newer information and booster authorizations suggest they should consider a third dose.

The Centers for Disease Control and Prevention (CDC) agreed with the FDA and has updated its vaccine recommendations to include a second booster.